(Q39036472)

8 September 2017

title

Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population (English)

1 reference

diffuse large B-cell lymphoma

8 September 2017

1 reference

1 reference

1 reference

Weiqun Chen

1

1 reference

8 September 2017

Hui Wang

2

1 reference

8 September 2017

Heming Chen

3

1 reference

8 September 2017

Shuiyi Liu

4

1 reference

8 September 2017

Hongda Lu

5

1 reference

8 September 2017

Deyong Kong

6

1 reference

8 September 2017

Xiaodong Huang

7

1 reference

8 September 2017

Qinzhi Kong

8

1 reference

8 September 2017

Zhongxin Lu

9

1 reference

8 September 2017

publication date

10 March 2014

1 reference

European Journal of Haematology

8 September 2017

published in

1 reference

8 September 2017

volume

92

1 reference

8 September 2017

issue

5

1 reference

8 September 2017

page(s)

407-412

1 reference

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

8 September 2017

cites work

1 reference

Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer.

21 January 2018

1 reference

Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer

21 January 2018

1 reference

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

21 January 2018

1 reference

Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas

21 January 2018

1 reference

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

21 January 2018

1 reference

Circulating microRNAs as noninvasive biomarkers in breast cancer

21 January 2018

1 reference

Quantitation of microRNAs by real-time RT-qPCR.

21 January 2018

1 reference

Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases

21 January 2018

1 reference

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

21 January 2018

1 reference

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma

21 January 2018

1 reference

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis

21 January 2018

1 reference

AP-1-Dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells

21 January 2018

1 reference

MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EJH.12263

1 reference

8 September 2017

1 reference